KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) FCF Margin (2016 - 2025)

Historic FCF Margin for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to 42.15%.

  • Jazz Pharmaceuticals' FCF Margin rose 53700.0% to 42.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.97%, marking a year-over-year decrease of 123300.0%. This contributed to the annual value of 33.37% for FY2024, which is 55200.0% up from last year.
  • According to the latest figures from Q3 2025, Jazz Pharmaceuticals' FCF Margin is 42.15%, which was up 53700.0% from 72.23% recorded in Q2 2025.
  • Jazz Pharmaceuticals' 5-year FCF Margin high stood at 46.55% for Q1 2021, and its period low was 72.23% during Q2 2025.
  • Its 5-year average for FCF Margin is 25.07%, with a median of 31.42% in 2022.
  • Its FCF Margin has fluctuated over the past 5 years, first soared by 265800bps in 2022, then tumbled by -1039000bps in 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' FCF Margin (Quarter) stood at 18.71% in 2021, then soared by 83bps to 34.21% in 2022, then plummeted by -55bps to 15.54% in 2023, then soared by 128bps to 35.41% in 2024, then grew by 19bps to 42.15% in 2025.
  • Its FCF Margin stands at 42.15% for Q3 2025, versus 72.23% for Q2 2025 and 35.41% for Q4 2024.